EPH68 SAFETY AND EFFECTIVENESS OF EGFR-TKI RECHALLENGE AFTER EGFR-TKI-ASSOCIATED INTERSTITIAL LUNG DISEASE IN ADVANCED NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE COHORT STUDY IN TAIWAN
Value in Health · 2026-06 · 29 (6) · S176-S177
DOI: 10.1016/j.jval.2026.03.900 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Value in Health, 2026-06. Verfasst von Yu-Yin Chen und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chen, Y., Chen, H., Huang, W., Chao, H., & Tsai, Y. (2026). EPH68 SAFETY AND EFFECTIVENESS OF EGFR-TKI RECHALLENGE AFTER EGFR-TKI-ASSOCIATED INTERSTITIAL LUNG DISEASE IN ADVANCED NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE COHORT STUDY IN TAIWAN. Value in Health, 29(6), S176-S177. https://doi.org/10.1016/j.jval.2026.03.900
Vancouver
Chen Y, Chen H, Huang W, Chao H, Tsai Y. EPH68 SAFETY AND EFFECTIVENESS OF EGFR-TKI RECHALLENGE AFTER EGFR-TKI-ASSOCIATED INTERSTITIAL LUNG DISEASE IN ADVANCED NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE COHORT STUDY IN TAIWAN. Value in Health. 2026;29(6):S176-S177. doi:10.1016/j.jval.2026.03.900
BibTeX
@article{Chen2026,
author = {Chen, Yu-Yin and Chen, Hsiao-Ling and Huang, Wei-ming and Chao, Heng-sheng and Tsai, Yi-Wen},
title = {EPH68 SAFETY AND EFFECTIVENESS OF EGFR-TKI RECHALLENGE AFTER EGFR-TKI-ASSOCIATED INTERSTITIAL LUNG DISEASE IN ADVANCED NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE COHORT STUDY IN TAIWAN},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S176--S177},
doi = {10.1016/j.jval.2026.03.900}
}
EUVIMED